Cite
[Application of Chimeric Antigen Receptor-Modified NK Cells in Multiple Myeloma].
MLA
Wei, Hua-Ping, et al. “[Application of Chimeric Antigen Receptor-Modified NK Cells in Multiple Myeloma].” Zhongguo Shi Yan Xue Ye Xue Za Zhi, vol. 26, no. 3, June 2018, pp. 796–801. EBSCOhost, https://doi.org/10.7534/j.issn.1009-2137.2018.03.027.
APA
Wei, H.-P., Yang, N., Gu, Z.-Y., Zhao, S.-S., Wang, F.-Y., Luo, L., Guan, L.-X., & Gao, C.-J. (2018). [Application of Chimeric Antigen Receptor-Modified NK Cells in Multiple Myeloma]. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 26(3), 796–801. https://doi.org/10.7534/j.issn.1009-2137.2018.03.027
Chicago
Wei, Hua-Ping, Nan Yang, Zhen-Yang Gu, Sha-Sha Zhao, Fei-Yan Wang, Lan Luo, Li-Xun Guan, and Chun-Ji Gao. 2018. “[Application of Chimeric Antigen Receptor-Modified NK Cells in Multiple Myeloma].” Zhongguo Shi Yan Xue Ye Xue Za Zhi 26 (3): 796–801. doi:10.7534/j.issn.1009-2137.2018.03.027.